Is radioembolization or sorafenib the best option for patients with hepatocellular carcinoma and portal vein invasion?

Ying Yang Liao; Jian Hong Zhong; Ning Fu Peng; Le Qun Li; Tie Jun Tong

doi:10.1111/liv.13208

Is radioembolization or sorafenib the best option for patients with hepatocellular carcinoma and portal vein invasion?

Ying Yang Liao, Jian Hong Zhong, Ning Fu Peng, Le Qun Li, Tie Jun Tong

Department of Mathematics

Research output: Contribution to journal › Letter › peer-review

5 Citations (Scopus)

Original language	English
Pages (from-to)	1715
Number of pages	1
Journal	Liver International
Volume	36
Issue number	11
DOIs	https://doi.org/10.1111/liv.13208
Publication status	Published - 1 Nov 2016

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1111/liv.13208

Cite this

@article{293249182f8d4c8990cd594940727f7e,

title = "Is radioembolization or sorafenib the best option for patients with hepatocellular carcinoma and portal vein invasion?",

author = "Liao, {Ying Yang} and Zhong, {Jian Hong} and Peng, {Ning Fu} and Li, {Le Qun} and Tong, {Tie Jun}",

year = "2016",

month = nov,

day = "1",

doi = "10.1111/liv.13208",

language = "English",

volume = "36",

pages = "1715",

journal = "Liver International",

issn = "1478-3223",